Your browser doesn't support javascript.
loading
Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
Whittum-Hudson, J A; An, L L; Saltzman, W M; Prendergast, R A; MacDonald, A B.
Affiliation
  • Whittum-Hudson JA; Wilmer Ophthalmological Institute, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21287-9142, USA.
Nat Med ; 2(10): 1116-21, 1996 Oct.
Article in En | MEDLINE | ID: mdl-8837610
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Bacterial Vaccines / Glycolipids / Chlamydia Infections / Chlamydia trachomatis / Trachoma / Antibodies, Anti-Idiotypic / Vaccination / Antibodies, Bacterial / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 1996 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Bacterial Vaccines / Glycolipids / Chlamydia Infections / Chlamydia trachomatis / Trachoma / Antibodies, Anti-Idiotypic / Vaccination / Antibodies, Bacterial / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 1996 Type: Article Affiliation country: United States